Apple Watch Series 9, Ultra 2 will sell without blood oxygen feature

Apple will remove the blood oxygen feature from its latest Apple Watches, a move that will allow the company to continue importing and selling the devices in the U.S. as it battles with Masimo in court.

The change came as a result of a patent dispute between Apple and medical tech company Masimo, which briefly caused Apple to be banned from selling and importing its latest Apple Watch variants in the U.S. Now, to comply with the court's decision, Apple redesigned the new Watch variants without the pulse oximeter, which is used to measure the oxygen saturation level of the user's blood.

Apple now has a notice on top of its Apple Watch website, warning users that the Apple Watch Series 9 and Ultra 2 now come without the feature. All mentions of the feature were removed from Apple's comparison tool for the Apple Watch as well.

Apple Watch owners who already have a model with a blood oxygen feature are not affected, and internationally Apple is still able to sell watches with the feature.

"Apple's appeal is ongoing, and we believe the US Court of Appeals for the Federal Circuit should reverse the USITC's decision. We strongly disagree with the USITC decision and resulting orders," Apple said in a statement issued late Wednesday.

Read more -here-

• OpenAI partners with Stack Overflow to make models better at coding
• Dropbox breach exposes customer credentials, authentication data
• Google: Passkey authentications top 1 billion across 400 million accounts
• FTC fines Razer for misrepresenting COVID masks as N95s
• FCC fines Verizon, AT&T other major carriers nearly $200 million for sharing customer data
• Federal regulators accuse Amazon executives of deleting messages